PROCEPT BioRobotics Director MOLL FREDERIC H Buys 20,000 Shares at $39.26/Share
ByAinvest
Friday, Aug 15, 2025 11:26 am ET1min read
PRCT--
The acquisition was reported through a SEC Form 4 filing, which provides detailed information about the transaction [1]. According to the filing, Moll directly owns 863,159 shares of the company following the purchase. The transaction was made at a weighted average price of $39.2569 per share, with individual prices ranging from $38.71 to $39.645 [2].
This investment by a high-ranking executive can be seen as a vote of confidence in the company's future performance. It is essential for investors to consider such insider transactions as they can provide insights into the company's prospects and management's confidence in its strategy.
Reference List:
[1] https://www.stocktitan.net/sec-filings/PRCT/form-4-procept-bio-robotics-corporation-insider-trading-activity-57590c11faee.html
[2] https://www.tradingview.com/news/tradingview:c734415568138:0-procept-biorobotics-corp-director-frederic-h-moll-acquires-20-000-shares/
PROCEPT BioRobotics Corp. recently announced that Director MOLL FREDERIC H has made a significant investment in the company by acquiring 20,000 shares at a price of $39.26 per share on August 13, 2025. This notable transaction reflects the Director's confidence in the company's prospects and demonstrates his commitment to the organization's long-term growth.
PROCEPT BioRobotics Corp. recently announced that Director MOLL FREDERIC H has made a significant investment in the company by acquiring 20,000 shares at a price of $39.26 per share on August 13, 2025. This notable transaction reflects the Director's confidence in the company's prospects and demonstrates his commitment to the organization's long-term growth.The acquisition was reported through a SEC Form 4 filing, which provides detailed information about the transaction [1]. According to the filing, Moll directly owns 863,159 shares of the company following the purchase. The transaction was made at a weighted average price of $39.2569 per share, with individual prices ranging from $38.71 to $39.645 [2].
This investment by a high-ranking executive can be seen as a vote of confidence in the company's future performance. It is essential for investors to consider such insider transactions as they can provide insights into the company's prospects and management's confidence in its strategy.
Reference List:
[1] https://www.stocktitan.net/sec-filings/PRCT/form-4-procept-bio-robotics-corporation-insider-trading-activity-57590c11faee.html
[2] https://www.tradingview.com/news/tradingview:c734415568138:0-procept-biorobotics-corp-director-frederic-h-moll-acquires-20-000-shares/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet